S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
Log in

ENDRA Life Sciences Stock Price, Forecast & Analysis (NASDAQ:NDRA)

$1.00
-0.05 (-4.76 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$0.99
Now: $1.00
$1.00
50-Day Range
$1.00
MA: $1.13
$1.37
52-Week Range
$0.90
Now: $1.00
$4.50
Volume800 shs
Average Volume63,587 shs
Market Capitalization$6.63 million
P/E RatioN/A
Dividend YieldN/A
Beta1.24
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NDRA
CUSIPN/A
Phone734-335-0468

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10,000.00
Book Value$0.94 per share

Profitability

Net Income$-9,800,000.00

Miscellaneous

Employees11
Market Cap$6.63 million
Next Earnings Date3/9/2020 (Estimated)
OptionableNot Optionable

Receive NDRA News and Ratings via Email

Sign-up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter.


ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions

What is ENDRA Life Sciences' stock symbol?

ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA."

When is ENDRA Life Sciences' next earnings date?

ENDRA Life Sciences is scheduled to release their next quarterly earnings announcement on Monday, March 9th 2020. View Earnings Estimates for ENDRA Life Sciences.

What price target have analysts set for NDRA?

3 brokers have issued twelve-month price objectives for ENDRA Life Sciences' stock. Their forecasts range from $6.00 to $6.00. On average, they expect ENDRA Life Sciences' share price to reach $6.00 in the next twelve months. This suggests a possible upside of 500.0% from the stock's current price. View Analyst Price Targets for ENDRA Life Sciences.

What is the consensus analysts' recommendation for ENDRA Life Sciences?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ENDRA Life Sciences in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ENDRA Life Sciences.

Has ENDRA Life Sciences been receiving favorable news coverage?

Media coverage about NDRA stock has trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. ENDRA Life Sciences earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for ENDRA Life Sciences.

Who are some of ENDRA Life Sciences' key competitors?

What other stocks do shareholders of ENDRA Life Sciences own?

Who are ENDRA Life Sciences' key executives?

ENDRA Life Sciences' management team includes the folowing people:
  • Mr. Francois Michelon, Chairman & CEO (Age 53)
  • Mr. David R. Wells, CFO & Sec. (Age 57)
  • Mr. Michael Thornton, Chief Technology Officer (Age 51)
  • Dr. Jonathan Behr Ph.D., Co-Founder
  • Mr. Steve Freeman, HR Leader

When did ENDRA Life Sciences IPO?

(NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO.

How do I buy shares of ENDRA Life Sciences?

Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ENDRA Life Sciences' stock price today?

One share of NDRA stock can currently be purchased for approximately $1.00.

How big of a company is ENDRA Life Sciences?

ENDRA Life Sciences has a market capitalization of $6.63 million and generates $10,000.00 in revenue each year. The company earns $-9,800,000.00 in net income (profit) each year or ($2.10) on an earnings per share basis. ENDRA Life Sciences employs 11 workers across the globe.View Additional Information About ENDRA Life Sciences.

What is ENDRA Life Sciences' official website?

The official website for ENDRA Life Sciences is http://www.endrainc.com/.

How can I contact ENDRA Life Sciences?

ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at [email protected]


MarketBeat Community Rating for ENDRA Life Sciences (NASDAQ NDRA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  204 (Vote Underperform)
Total Votes:  379
MarketBeat's community ratings are surveys of what our community members think about ENDRA Life Sciences and other stocks. Vote "Outperform" if you believe NDRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel